Showing results (101-110 of 297) with videos related to

Sort By:
Pageof 30
NPJ Breast Cancer|April 17, 2026
Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trialsSimon Udovica, Rupert Bartsch, Christian F Singer, et al.
Fertility and Sterility|June 12, 2010
Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexualsEva-Katrin Bentz, Dietmar Pils, Martin Bilban, et al.
Cancer Medicine|March 2, 2019
Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patientsChristian F Singer, Yen Y Tan, Daniela Muhr, et al.
Plos One|July 5, 2013
Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assayChristian F Singer, Florian Klinglmüller, Rembert Stratmann, et al.
Molecular Genetics & Genomic Medicine|April 12, 2016
Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriersViktoria Rieder, Mohamed Salama, Lena Glöckner, et al.
Breast Cancer Research and Treatment|November 4, 2010
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cellsCaroline Brünner-Kubath, Waheed Shabbir, Victoria Saferding, et al.
Breast Cancer Research : BCR|September 26, 2013
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancerRebecca A Dent, Geoffrey J Lindeman, Mark Clemons, et al.
Endocrine-Related Cancer|October 25, 2008
Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cellsChristian F Singer, Gernot Hudelist, Eva-Maria Fuchs, et al.
Cancers|May 4, 2026
Gene-Specific Outcomes After Central Nervous System Metastases in Germline BRCA1- and BRCA2-Associated Breast CancerAlice Decaminada, Raute Sunder-Plassmann, Weang-Kee Ho, et al.
BMC Cancer|March 28, 2023
Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer"Christine Deutschmann, Christian F Singer, Daphne Gschwantler-Kaulich, et al.
Pageof 30